BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 30264354)

  • 1. Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.
    Chambers ES; Preston T; Frost G; Morrison DJ
    Curr Nutr Rep; 2018 Dec; 7(4):198-206. PubMed ID: 30264354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short chain fatty acids in human gut and metabolic health.
    Blaak EE; Canfora EE; Theis S; Frost G; Groen AK; Mithieux G; Nauta A; Scott K; Stahl B; van Harsselaar J; van Tol R; Vaughan EE; Verbeke K
    Benef Microbes; 2020 Sep; 11(5):411-455. PubMed ID: 32865024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and energy balance: role in obesity.
    Blaut M
    Proc Nutr Soc; 2015 Aug; 74(3):227-34. PubMed ID: 25518735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the gastrointestinal microbiota be modulated by dietary fibre to treat obesity?
    Davis HC
    Ir J Med Sci; 2018 May; 187(2):393-402. PubMed ID: 29038988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
    Nogal A; Valdes AM; Menni C
    Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Fermentation Patterns of Rice Bran Components by Human Gut Microbiota.
    Pham T; Teoh KT; Savary BJ; Chen MH; McClung A; Lee SO
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.
    Zhang HY; Tian JX; Lian FM; Li M; Liu WK; Zhen Z; Liao JQ; Tong XL
    Biomed Pharmacother; 2021 Jan; 133():110857. PubMed ID: 33197760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials.
    Myhrstad MCW; Tunsjø H; Charnock C; Telle-Hansen VH
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32210176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.
    Bach Knudsen KE; Lærke HN; Hedemann MS; Nielsen TS; Ingerslev AK; Gundelund Nielsen DS; Theil PK; Purup S; Hald S; Schioldan AG; Marco ML; Gregersen S; Hermansen K
    Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
    Morrison DJ; Preston T
    Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
    Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
    Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Glycosidic Bond Configuration on Short Chain Fatty Acid Production from Model Fermentable Carbohydrates by the Human Gut Microbiota.
    Harris HC; Edwards CA; Morrison DJ
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28045429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
    Tuohy KM; Fava F; Viola R
    Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity.
    Hernández MAG; Canfora EE; Jocken JWE; Blaak EE
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
    de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence meets function-microbiota and cardiovascular disease.
    Kim M; Huda MN; Bennett BJ
    Cardiovasc Res; 2022 Jan; 118(2):399-412. PubMed ID: 33537709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-chain fatty acids as a link between diet and cardiometabolic risk: a narrative review.
    Birkeland E; Gharagozlian S; Valeur J; Aas AM
    Lipids Health Dis; 2023 Mar; 22(1):40. PubMed ID: 36915164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fibre-based SCFA mixtures promote both protection and repair of intestinal epithelial barrier function in a Caco-2 cell model.
    Chen T; Kim CY; Kaur A; Lamothe L; Shaikh M; Keshavarzian A; Hamaker BR
    Food Funct; 2017 Mar; 8(3):1166-1173. PubMed ID: 28174773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease.
    Wijdeveld M; Nieuwdorp M; IJzerman R
    Expert Opin Ther Targets; 2020 Jul; 24(7):639-653. PubMed ID: 32441559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of long-term dietary pattern of fecal donor on in vitro fecal fermentation properties of inulin.
    Yang J; Rose DJ
    Food Funct; 2016 Apr; 7(4):1805-13. PubMed ID: 26583778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.